1. Cancer Immunotherapy Drugs Show Efficacy In Early, Mid-Stage Trials http://www.bidnessetc.com/26533-cancer-immunotherapy-drugs-show-efficacy-in-early-midstage-trials/ $RHHBY $MRK $AZN

  2. Cancer Immunotherapy Drugs Show Efficacy In Early, Mid-Stage Trials http://www.bidnessetc.com/26533-cancer-immunotherapy-drugs-show-efficacy-in-early-midstage-trials/ $RHHBY $MRK $AZN

  3. @ckbike Would be nice to know circumstances of Ms. Laux s leaving at $MRK. Hiring could be a negative.

  4. @princetan777 I d take $MRK :-)

  5. $MNKD Are we Approved yet in countries outside USA? Where? When? $otiv $attbf $srna $jd $aapl $sny $mrk $mdt $pfe $bayry $nvs $gsk $lly $v

  6. Another Success For Bristol-Myers‘ PD-1 Immunotherapy Drug http://y.ahoo.it/AxuD5u9n $BMY $MRK $GSK $RHHBY

  7. Timberline Investment Management holds an allocation of 2.8% in $MRK in his Dividend and Growth Investment Portfolio

  8. Stocks Getting A Boost From Pricey Drugs $GILD $BMY $MRK http://y.ahoo.it/m46DKaXo

  9. Interesting November Stock Options for $MRK http://y.ahoo.it/RHWRVan1

  10. Pharma Events To Watch Out For This Week http://y.ahoo.it/szAeAWB8 $MRK $SLXP $PGNX $GILD $ABBV $ICPT

  11. $MRK Keytruda Effective In Fighting Stomach Cancer http://y.ahoo.it/7zPI3PZF $BMY $AZN $RHHBY

  12. $MNKD: $MRK, $NVO, $AZN could do more than a good enough of a job with Afrezza. Banking off Lantus success had $SNY twisted $MNKD arms. JMo

  13. @wildpig partner. So much hype about $SNY . No wonder they got their hands bent backwards. $MRK could do just enough to see Afrezza JMO

  14. Why Drug Maker Wears Red – $MRK , $BMY, $AGN http://y.ahoo.it/TswQsf2n

  15. AstraZeneca presented promising trial data for PDL-1 inhibitor, MEDI4736, at the ESMO 2014 Congress $AZN $MRK $BMY

  16. $MRK Merck Presents Early Data on Investigational Use of KEYTRUDA in Patients with Advanced Bladder Cancer at ESMO 2014

  17. $MRK Merck Announces First Presentation of Early Data on the Investigational Use of KEYTRUDA(R) (pembrolizumab) in http://y.ahoo.it/Dg6gqyIH

  18. Stocks Fight Off Predictable Weakness, But Expect More Downside $SPY $VIX $JNJ $DIS $UNH $MRK $INTC http://y.ahoo.it/nggjkTFd

  19. $MRK Merck Announces First Presentation of Data on the Investigational Use of KEYTRUDA(R) (pembrolizumab) in http://y.ahoo.it/h8Q8RSQk

  20. @SwingVector @evetsoloccip @wildpig Lol swing you might never know.I keep saying why did $MRK accommodate $AMPH then $MNKD made that deal??

  21. Parabolic Sar Sell Signals 2/3 $GNC $GS $HCA $HGR $HMIN $HUM $ING $KR $MON $MRK $NXPI $ONB $PG $PM http://y.ahoo.it/vpIc97NV

  22. Did $MRK get railroaded by $MNKD after they sold the plant to $AMPH what does $MRK get from making this accomodation?

  23. @Factfinder ...also $MRK made acommodative risk with that deal with $AMPH then $MNKD deal with $AMPH. $MRK trying to get in on the action

  24. $MNKD better produce someother annoucement. what have Greenhill done? Is Greenhill have a pending deal on the table?. $MDT/$MRK/$SNY$PFE

  25. @TheWhiteRabbit Which others? $BMS has to be given with Sovaldi. $ABBV needs Ribavirin, $MRK still unproven waiting on Idenix study reults!